ARTICLE

A SYNOPSIS OF THE CURRENT SCENARIO OF DIABETES MELLITUS IN PAKISTAN

  1. HOME
  2. ARTICLE

03 Pages : 21-35

http://dx.doi.org/10.31703/giidr.2016(I-I).03      10.31703/giidr.2016(I-I).03      Published : Dec 2016

A Synopsis of the Current Scenario of Diabetes Mellitus in Pakistan

Abstract

    Diabetes mellitus is one of the most frequently encountered diseases in human history, and it is triggered mostly by two factors: one is genetic and the other environmental. According to the World Health Organization, one in every four individuals is diabetic or pre-diabetic, which is a frightening statistic. During the Coronavirus pandemic, there is also a significant setback in the management of diabetes due to lockdown, many diabetes patients suffered greatly, and unfortunately, a large number of elderly diabetics kicked the bucket after contracting SARSCoV-2 last year as their already compromised immune system could not combat Covid-19. Now, more than ever, there is an urgent need to raise public awareness about the benefits of maintaining a healthy diet and to promote campaigns about how to avoid the onset of diabetes myelitis through lifestyle modifications

    Healthy Lifestyle, Pre-Diabetic, Compromised Immunity, SARS-CoV-2, Campaigns, Incidences, Prevalence

    (1) Rumla Khan
    Undergraduate Student, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
    (2) Murtaza Hussain
    Undergraduate Student, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
    (3) Kiran Shehzadi
    Undergraduate Student, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
    (4) Muhammad Khalid Tipu
    Assistant Professor, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
Fulltext PDF

References

  • Aamir, A. H. et al. (2019) 'Diabetes Prevalence Survey of Pakistan (DPS-PAK): Prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: A popula#on-based survey from Pakistan', BMJ Open, 9(2), pp. 1-9. DOI: 10.1136/bmjopen-2018-025300.
  • Adnan, M. & Aasim, M. (2020) 'Prevalence of type 2 diabetes mellitus in adult popula#on of Pakistan: A meta-analysis of prospec#ve cross-sec#onal surveys', Annals of Global Heal!, 86(1), pp. 1-8. DOI: 10.5334/aogh.2679.
  • Aref, A. et al. (2019) 'Pancrea#c transplanta#on: Brief review of !e current evidence', World Journal of Transplanta#on, 9(4), pp. 81-93. DOI: 10.5500/wjt.v9.i4.81.
  • Aroda, V. R. & Ratner, R. E. (2018) 'Metformin and type 2 diabetes preven#on, Diabetes Spectrum, 31(4), pp. 336-342. DOI: 10.2337/ds18-0020.
  • Benjamin, B. K. et al. (2021) 'The Associa#on between Type-2 Diabetes Dura#on and Major Adverse Cardiac Events after Percutaneous Coronary Interven#on', 2021.
  • Bisson, A. et al. (2021) 'Sex, age, type of diabetes and incidence of atrial fibrilla#on in pa#ents wi! diabetes mellitus: a na#onwide analysis', Cardiovascular Diabetology. BioMed Central, 20(1), pp. 1-11. DOI: 10.1186/s12933-021-01216-7.
  • Buras, E. D. et al. (2019) ‘Fibro-adipogenic remodeling of !e diaphragm in obesity - associated respiratory dysfunc#on', diabetes, 68(1), pp. 45-56. DOI: 10.2337/db18-0209.
  • Care, D. & Suppl, S. S. (2021a) '2. Classifica#on and Diagnosis of Diabetes : .andards of Medical Care in Diabetes d 2021', 44(January), pp. 15-33. DOI: 10.2337/dc21-S002.
  • Care, D. & Suppl, S. S. (2021b) 'Pharmacologic approa'es to glycemic treatment: .andards of medical care in diabetesd2021', Diabetes Care, 44(January), pp. S111-S124. DOI: 10.2337/dc21-S009.
  • Das, S. et al. (2020) 'Since January 2020 Elsevier has created a COVID-19 resource center wi! free informa#on in English and Mandarin on !e novel coronavirus COVID - 19. The COVID-19 resource center is hosted on Elsevier Connect, !e company's public news and informa#on ', (January).
  • Da(a, B. K., Husain, M. J. & Asma, S. (2019) 'Assessing !e rela#onship between out - of-poet spending on bl*d pressure and diabetes medica#on and household catastrophic heal! expenditure: Evidence from Pakistan', Interna#onal Journal for Equity in Heal!. Interna#onal Journal for Equity in Heal!, 18(1), pp. 1-12. DOI: 10.1186/s12939-018-0906-x.
  • Forbes, J. M. & Fo!eringham, A. K. (2017) ‘Vascular complica#ons in diabetes: old messages, new !oughts', Diabetologia. Diabetologia, 60(11), pp. 2129-2138. DOI: 10.1007/s00125-017-4360-x.
  • Gillani, A. H. et al. (2018) 'Direct and indirect cost of diabetes care among pa#ents wi! type 2 diabetes in private clinics: a mul#center study in Punjab, Pakistan', Expe) Review of Pharmacoeconomics and Outcomes Resear'. Taylor and Francis Ltd, 18(6), pp. 647-653. DOI:10.1080/14737167.2018. 1503953.
  • Grujić, M. & Petronijević-Novak, S. (1988) ‘[Dental and oral aspects of diabetes mellitus].', .omatoloski glasnik Srbije, 24(1), pp. 39- 44. Available at http://www.ncbi.nlm.nih. gov/pubmed/288207.
  • Gupta, R., Hussain, A. & Misra, A. (2020) 'Diabetes and COVID-19: evidence, current status, and unanswered resear' questions', European Journal of Clinical Nutri#on. Springer US, 74(6), pp. 864-870. DOI: 10.1038/s41430-020-0652-1
  • Huang, J. et al. (2021) 'Mul#focal Electrore#nogram Can Detect !e Abnormal Re#nal -ange in Early .age of type2 DM Pa#ents wi!out Apparent Diabe#c Re#nopa!y', 2021.
  • Hussain, A., Bhowmik, B. & do Vale Moreira, N. C. (2020) 'COVID-19 and diabetes: Knowledge in progress', Diabetes Resear' and Clinical Prac#ce. The au!or (s), 162, p. 108142. DOI: 10.1016/j.diabres.2020.108142.
  • Imam, M. U. & Ismail, M. (2017) 'The Impact of Tradi#onal F*d and Lifestyle Behavior on Epigene#c Burden of -ronic Disease', Global -allenges, 1(8), p. 1700043. DOI: 10.1002/g'2.201700043.
  • Joseph, A., Parva!y, S. & Varma, K. K. (2021) ‘Hyperinsulinemia Induced Altered Insulin Signaling Pa!way in Muscle of High Fat- and Carbohydrate-Fed Rats : Effect of Exercise', 2021.
  • Kumah, E. et al. (2021) 'Review A)icle Influence of !e Model of Care on !e Outcomes of Diabetes Self- Management Educa#on Program : A Scoping Review', 2021.
  • Leite, R. G. O. F. et al. (2020) 'Effec#veness of non- pharmacological strategies in !e management of type 2 diabetes in primary care: A protocol for a systema#c review and network meta-analysis', BMJ Open, 10(1), pp. 1-7. DOI: 10.1136/bmjopen-2019- 034481.
  • Lever, M. et al. (2012) 'Variability of plasma and urine betaine in diabetes mellitus and its rela#onship to me!ionine load test responses : an observa#onal study', pp. 1- 8.
  • Lin, X. et al. (2020) 'Global, regional, and na#onal burden and trend of diabetes in 195 countries and territories : an analysis from 1990 to 2025', Scien#fic Repo)s. Nature Publishing Group UK, (0123456789), pp. 1-11. DOI: 10.1038/s41598-020-71908-9.
  • Liu, Z. et al. (2021) 'The Effect of Momordica 'aran#a in !e Treatment of Diabetes Mellitus: A Review', Evidence-based Complementary and Alterna#ve Medicine, 2021. DOI: 10.1155/2021/3796265.
  • Longo, M. et al. (2020) 'Trea#ng type 2 diabetes in COVID-19 pa#ents: The poten#al benefits of injec#ve !erapies', Cardiovascular Diabetology. BioMed Central, 19(1), pp. 1- 5. DOI: 10.1186/s12933-020-01090-9.
  • Mehm*d, K. & Junaid, N. (2018) ‘Prevalence of undiagnosed type 2 diabetes mellitus in Pakistan: Results of SCREEN-diabetes disease registry', Journal of !e Pakistan Medical Associa#on, 68(8), pp. 1171-1178.
  • Morris, D. (2020) ',at is !e effect of COVID-19 on people wi! diabetes?', Independent Nurse, 2020(5), pp. 12-17. DOI: 10.12968/indn.2020.5.12.
  • Ng, K. E. & Riard, J. P. (2020) 'The Effect of COVID-19 on Pa#ents Wi! Diabetes', diabetes, 45(11), pp. 9-12.
  • Of, C. et al. (2005) 'DIABETES MELLITUS AND OTHER CATEGORIES OF DESCRIPTION OF DIABETES', 28.
  • Papa!eodorou, K. et al. (2018) 'Complica#ons of Diabetes 2017', Journal of Diabetes Resear', 2018. DOI: 10.1155/2018/3086167.
  • Sas, L. J. et al. (2020) 'Considera#ons for people wi! diabetes during !e Coronavirus Disease (COVID-19) pandemic', Diabetes Resear' and Clinical Prac#ce. Elsevier B.V., 166, p. 108296. DOI: 10.1016/j.diabres.2020.108296.
  • Saeedi, P. et al. (2019) 'Global and regional diabetes prevalence estimates for 2019 and projec#ons for 2030 and 2045: Results from !e Interna#onal Diabetes Federa#on Diabetes Atlas, 9! edi#on', Diabetes Resear' and Clinical Prac#ce. Elsevier Ireland Ltd, 157, p. 107843. DOI: 10.1016/j.diabres.2019.107843.
  • Sena, C. M. et al. (2010) ‘Diabetes mellitus: New 'allenges and innova#ve !erapies', EPMA Journal, 1(1), pp. 138-163. DOI: 10.1007/s13167-010-0010-9.
  • Shan, R., Sarkar, S. & Ma)in, S. S. (2019) 'Digital heal! te'nology and mobile devices for !e management of diabetes mellitus : state of !e a)'. Diabetologia, pp. 877-887.
  • Talley, N. J. et al. (2001) ‘Psy'ological distress is linked to gastrointestinal symptoms in diabetes mellitus' American Journal of Gastroenterology, 96(4), pp. 1033-1038. DOI: 10.1016/S0002-9270(00)02398-4.
  • Ugwueze, C. V. et al. (2020) ‘COVID-19 and Diabetes Mellitus: The Link and Clinical Implica#ons', Dubai Diabetes and Endocrinology Journal, 26(2), pp. 69-77. DOI: 10.1159/000511354.
  • Verhulst, M. J. L. et al. (2019) 'Evalua#ng all poten#al oral complica#ons of diabetes mellitus', Fron#ers in Endocrinology, 10(FEB). DOI: 10.3389/fendo.2019.00056.
  • Yu, M. (2020) 'The Place of Sulfonylureas in !e Evolving Landscape of Combina#on Therapy', Diabetes Therapy. Springer Heal!care, 11(s1), pp. 23-28. DOI: 10.1007/s13300-020-00813-1.
  • Zhao, R. et al. (2021) 'Nontradi#onal Therapy of Diabetes and Its Complica#ons', Journal of Diabetes Resear', 2021, pp. 1-5. DOI: 10.1155/2021/1592049.

Cite this article

APA

    APA : Khan, R., Hussain, M., & Shehzadi, K. (2016). A Synopsis of the Current Scenario of Diabetes Mellitus in Pakistan. Global Immunological & Infectious Diseases Review, I(I), 21-35. https://doi.org/10.31703/giidr.2016(I-I).03

CHICAGO

    CHICAGO : Khan, Rumla, Murtaza Hussain, and Kiran Shehzadi. 2016. "A Synopsis of the Current Scenario of Diabetes Mellitus in Pakistan." Global Immunological & Infectious Diseases Review, I (I): 21-35 doi: 10.31703/giidr.2016(I-I).03

HARVARD

    HARVARD : KHAN, R., HUSSAIN, M. & SHEHZADI, K. 2016. A Synopsis of the Current Scenario of Diabetes Mellitus in Pakistan. Global Immunological & Infectious Diseases Review, I, 21-35.

MHRA

    MHRA : Khan, Rumla, Murtaza Hussain, and Kiran Shehzadi. 2016. "A Synopsis of the Current Scenario of Diabetes Mellitus in Pakistan." Global Immunological & Infectious Diseases Review, I: 21-35

MLA

    MLA : Khan, Rumla, Murtaza Hussain, and Kiran Shehzadi. "A Synopsis of the Current Scenario of Diabetes Mellitus in Pakistan." Global Immunological & Infectious Diseases Review, I.I (2016): 21-35 Print.

OXFORD

    OXFORD : Khan, Rumla, Hussain, Murtaza, and Shehzadi, Kiran (2016), "A Synopsis of the Current Scenario of Diabetes Mellitus in Pakistan", Global Immunological & Infectious Diseases Review, I (I), 21-35

TURABIAN

    TURABIAN : Khan, Rumla, Murtaza Hussain, and Kiran Shehzadi. "A Synopsis of the Current Scenario of Diabetes Mellitus in Pakistan." Global Immunological & Infectious Diseases Review I, no. I (2016): 21-35. https://doi.org/10.31703/giidr.2016(I-I).03